Chemoprevention of Colorectal Cancer with 5-Aminosalicylic Acids in adult patients with Inflammatory Bowel Disease

Keywords

Medicine, Colorectal cancer, Odds ratio, Internal medicine, Inflammatory bowel disease

References

• Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.Javier Benayas del Álamo — 1989
• Colorectal cancer prevention in ulcerative colitis: a case‐control studyClaire-Lise Dautry — 2000
• Risk factors for colorectal cancer in Crohn's colitis: A case‐control studyCorey A. Siegel, Bruce E. Sands — 2006
• 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological studyTjeerd van Staa, T Card, R F Logan — 2005
• Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.Dan Pinczowski, Anders Ekbom, John A. Baron — 1994
• Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel DiseaseJeffrey Tang, Omar Sharif, Chetan Pai — 2010
• Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control studyPer Karlén, Dan Kornfeld, Olle Broström — 1998
• Cancer morbidity in ulcerative colitis.P Prior, S N Gyde, J. C. Macartney — 1982
• Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.Matthew D. Rutter, Brian P. Saunders, Kay H. Wilkinson — 2004
• Family history as a risk factor for colorectal cancer in inflammatory bowel disease.Johan Askling, Paul W. Dickman, Anders Ekbom — 2001
• Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.David T. Rubin, Andelka LoSavio, Nicole Yadron — 2006
• Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?Çharles N. Bernstein, Colleen Metge, James Blanchard — 2003
• Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.Fernando Velayos, Edward V. Loftus, Tine Jess — 2006
• Mesalazine‐induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?Bus, Irıs D. Nagtegaal, Verspaget — 1999
• Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.Steven J. Shiff, Markos I. Koutsos, Liang Qiao — 1996
• Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease.MARK E. RICHARDS, Robert R. Rickert, Francis C. Nance — 1989
• 5‐Aminosalicylic Acid Therapy and the Risk of Colorectal Cancer Among Patients with Inflammatory Bowel DiseaseJonathan P. Terdiman, Michael Steinbuch, William A. Blumentals — 2007
• The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitisPierenrico Marchesa, B A Lashner, Ian C. Lavery — 1999
• Increased risk of large-bowel cancer in Crohn's disease with colonic involvement.Anders Ekbom, H-O Adami, C. G. Helmick — 1990
• Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort StudiesTine Jess, Michael Gamborg, Peter Matzen — 2005

Cited by

• Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel diseaseAjit Sood, Vineet Ahuja, Vandana Midha — 2020

Related papers

• Advances in Chemoprevention of Colorectal Cancer in Patients with Inflammatory Bowel DiseaseRan Zhihu — 2008
• Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the RiskLászló Herszényi, Lóránd Barabás, Pál Miheller — 2014
• Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and SurveillanceZhenhua Wang, Jing‐Yuan Fang — 2014
• Prevention of Colorectal Cancer in Inflammatory Bowel Disease: Value of Screening and 5-AminosalicylatesPia Munkholm, Edward V. Loftus, Anke Reinacher‐Schick — 2006
• How to manage the risk of colorectal cancer in ulcerative colitis.Raja Affendi Raja Ali, Laurence J. Egan — 2011